The long-term safety of many antiobesity pharmacologic regimens has not been adequately evaluated. If recommended and prescribed, pharmacologic agents should be an adjunct to a structured diet and exercise regimen. Unfortunately, weight gain after discontinuation of antiobesity agents is common. In addition, the effect of weight loss obtained through the use of pharmacotherapeutic agents on overall morbidity and mortality has not been established.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.pop.2009.01.004 | DOI Listing |
Publication Analysis
Top Keywords
pharmacotherapy obese
4
obese patient
4
patient long-term
4
long-term safety
4
safety antiobesity
4
antiobesity pharmacologic
4
pharmacologic regimens
4
regimens adequately
4
adequately evaluated
4
evaluated recommended
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!